Hollsteen
← Coherent

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: $735M · 10-Q 0001564590-15-009922 filed Nov 6, 2015Equity incl. NCI · Q2 FY2016: $752M · 10-Q 0001564590-16-012460 filed Feb 8, 2016Equity incl. NCI · Q3 FY2016: $778M · 10-Q 0001564590-16-018663 filed May 9, 2016Equity incl. NCI · Q4 FY2016: $782M · 10-K 0001564590-16-024750 filed Aug 26, 2016Equity incl. NCI · Q1 FY2017: $801M · 10-Q 0001564590-16-028337 filed Nov 8, 2016Equity incl. NCI · Q2 FY2017: $819M · 10-Q 0001564590-17-000837 filed Feb 1, 2017Equity incl. NCI · Q3 FY2017: $853M · 10-Q 0001564590-17-008137 filed May 2, 2017Equity incl. NCI · Q4 FY2017: $901M · 10-K 0001564590-17-017901 filed Aug 21, 2017Equity incl. NCI · Q1 FY2018: $944M · 10-Q 0001564590-17-022732 filed Nov 8, 2017Equity incl. NCI · Q2 FY2018: $964M · 10-Q 0001564590-18-001697 filed Feb 8, 2018Equity incl. NCI · Q3 FY2018: $1.0B · 10-Q 0001564590-18-012438 filed May 9, 2018Equity incl. NCI · Q4 FY2018: $1.0B · 10-K 0001564590-18-022409 filed Aug 28, 2018Equity incl. NCI · Q1 FY2019: $1.0B · 10-Q 0001564590-18-028645 filed Nov 8, 2018Equity incl. NCI · Q2 FY2019: $1.1B · 10-Q 0001564590-19-002429 filed Feb 8, 2019Equity incl. NCI · Q3 FY2019: $1.1B · 10-Q 0001564590-19-017964 filed May 9, 2019Equity incl. NCI · Q4 FY2019: $1.1B · 10-K 0001564590-19-032471 filed Aug 16, 2019Equity incl. NCI · Q1 FY2020: $2.1B · 10-Q 0001564590-19-042658 filed Nov 12, 2019Equity incl. NCI · Q2 FY2020: $2.1B · 10-Q 0001564590-20-004069 filed Feb 10, 2020Equity incl. NCI · Q3 FY2020: $2.0B · 10-Q 0000820318-20-000006 filed May 11, 2020Equity incl. NCI · Q4 FY2020: $2.1B · 10-K 0000820318-20-000023 filed Aug 26, 2020Equity incl. NCI · Q1 FY2021: $3.0B · 10-Q 0000820318-20-000029 filed Nov 9, 2020Equity incl. NCI · Q2 FY2021: $3.2B · 10-Q 0000820318-21-000004 filed Feb 9, 2021Equity incl. NCI · Q3 FY2021: $3.3B · 10-Q 0000820318-21-000012 filed May 7, 2021Equity incl. NCI · Q4 FY2021: $3.4B · 10-K 0000820318-21-000017 filed Aug 20, 2021Equity incl. NCI · Q1 FY2022: $3.5B · 10-Q 0000820318-21-000022 filed Nov 9, 2021Equity incl. NCI · Q2 FY2022: $3.5B · 10-Q 0000820318-22-000004 filed Feb 9, 2022Equity incl. NCI · Q3 FY2022: $3.6B · 10-Q 0000820318-22-000010 filed May 10, 2022Equity incl. NCI · Q4 FY2022: $3.6B · 10-K 0000820318-22-000019 filed Aug 29, 2022Equity incl. NCI · Q1 FY2023: $5.0B · 10-Q 0000820318-22-000027 filed Nov 9, 2022Equity incl. NCI · Q2 FY2023: $5.2B · 10-Q 0000820318-23-000005 filed Feb 8, 2023Equity incl. NCI · Q3 FY2023: $5.2B · 10-Q 0000820318-23-000009 filed May 10, 2023Equity incl. NCI · Q4 FY2023: $5.0B · 10-K 0000820318-23-000016 filed Aug 18, 2023Equity incl. NCI · Q1 FY2024: $4.8B · 10-Q 0000820318-23-000029 filed Nov 7, 2023Equity incl. NCI · Q2 FY2024: $5.8B · 10-Q 0000820318-24-000004 filed Feb 6, 2024Equity incl. NCI · Q3 FY2024: $5.7B · 10-Q 0000820318-24-000009 filed May 7, 2024Equity incl. NCI · Q4 FY2024: $5.6B · 10-K 0000820318-24-000016 filed Aug 16, 2024Equity incl. NCI · Q1 FY2025: $5.9B · 10-Q 0000820318-24-000035 filed Nov 6, 2024Equity incl. NCI · Q2 FY2025: $5.5B · 10-Q 0000820318-25-000004 filed Feb 5, 2025Equity incl. NCI · Q3 FY2025: $5.7B · 10-Q 0000820318-25-000009 filed May 7, 2025Equity incl. NCI · Q4 FY2025: $6.0B · 10-K 0000820318-25-000014 filed Aug 15, 2025Equity incl. NCI · Q1 FY2026: $6.2B · 10-Q 0000820318-25-000019 filed Nov 5, 2025Equity incl. NCI · Q2 FY2026: $8.9B · 10-Q 0000820318-26-000006 filed Feb 4, 2026Equity incl. NCI · Q3 FY2026: $11.0B · 10-Q 0000820318-26-000013 filed May 6, 2026Equity incl. NCI · Q4 FY2026: $11.2B · 10-K 0000820318-26-000020 filed Aug 14, 20263.411.20.7Q1 FY2016Q4 FY2026Q4 FY2021
Q4 FY2021
3.4$B
All values (44)
PeriodValue ($B)Status
Q4 FY202611.2reported
Q3 FY202611.0reported
Q2 FY20268.9reported
Q1 FY20266.2reported
Q4 FY20256.0reported
Q3 FY20255.7reported
Q2 FY20255.5reported
Q1 FY20255.9reported
Q4 FY20245.6reported
Q3 FY20245.7reported
Q2 FY20245.8reported
Q1 FY20244.8reported
Q4 FY20235.0reported
Q3 FY20235.2reported
Q2 FY20235.2reported
Q1 FY20235.0reported
Q4 FY20223.6reported
Q3 FY20223.6reported
Q2 FY20223.5reported
Q1 FY20223.5reported
Q4 FY20213.4reported
Q3 FY20213.3reported
Q2 FY20213.2reported
Q1 FY20213.0reported
Q4 FY20202.1reported
Q3 FY20202.0reported
Q2 FY20202.1reported
Q1 FY20202.1reported
Q4 FY20191.1reported
Q3 FY20191.1reported
Q2 FY20191.1reported
Q1 FY20191.0reported
Q4 FY20181.0reported
Q3 FY20181.0reported
Q2 FY20181.0reported
Q1 FY20180.9reported
Q4 FY20170.9reported
Q3 FY20170.9reported
Q2 FY20170.8reported
Q1 FY20170.8reported
Q4 FY20160.8reported
Q3 FY20160.8reported
Q2 FY20160.8reported
Q1 FY20160.7reported

CSV with all sources · Technical ID: equity_total

More metrics for Coherent
Sources & calculation
Value
$3.4B
Period
Q4 FY2021, ended Jun 30, 2021 · as of Jun 30, 2021 (balance as of date, not a sum)
Source
10-K, filed Aug 20, 2021 · 0000820318-21-000017
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$3.4BAug 20, 202110-K 0000820318-21-000017reported · confidence 1. · current